• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
dominoes stop stall halt end red
Biotech

'Several concerning observations': FDA sheds light on rejections

The FDA’s ongoing effort to establish a culture of “radical transparency” saw the agency publish another haul of complete response letters yesterday.
James Waldron Sep 5, 2025 10:45am
Abstract purple and magenta ribbon-like design layered over a collage of black-and-white portraits of Fierce 50 honorees in h
Favicon Fierce Pharma

Fierce 50 of 2025

Sep 2, 2025 4:30am
Senseonics Eversense 365 placed on arm

Senseonics to retake Eversense commercial control from Ascensia

Sep 5, 2025 2:00pm
Medtronic Hugo robotic surgery console

Medtronic’s Hugo robot logs success in hernia repair trial

Sep 5, 2025 12:00pm
sword fight onward path sunset sun rise

Braveheart pays $65M to challenge BMS for heart disease market

Sep 5, 2025 9:05am
Professional kite surfer soars through the air

Merck KGaA lands new R&D chief—Chutes & Ladders

Sep 5, 2025 8:30am
More News

BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3

Sep 5, 2025 7:30am

Fierce Biotech Fundraising Tracker: MRM Health, Treeline & more

Sep 4, 2025 4:15pm
Fierce Pharma

RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation

Sep 4, 2025 3:51pm

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings